Tatva Chintan Pharma Chem Board Approves Financials, Director Re-appointments, Expansion

Tatva Chintan Pharma Chem Limited's Board of Directors, in a meeting held on July 17, 2026, approved the unaudited financial results (standalone and consolidated) for the quarter ended June 30, 2026, along with the limited review report. The board also approved the re-appointment of Mr. Chintan Nitinkumar Shah as Managing Director and Mr. Ajaykumar Mansukhlal Patel and Mr. Shekhar Rasiklal Somani as Whole-time Directors, each for a further period of three years from February 1, 2027, subject to shareholder approval. Additionally, the company greenlit a capacity expansion for specialty chemicals at its Dahej unit and an increase in borrowing limits from ₹300 crore to ₹1,000 crore, also pending member approval.